[1]
siraj, N. et al. 2023. Extracellular Vesicles as Promising Vectors for CRISPR/Cas9 Delivery: Advantages, Challenges, and Clinical Implications. Trends in Pharmaceutical Biotechnology. 1, 1 (Jun. 2023), 19–33. DOI:https://doi.org/10.57238/tpb.2023.144271.1002.